About this trial
This study aims to compare 2 different groups of patients with both a healed site in the upper posterior sector after extractions, one treated with ultra-short implants, and another with long implants with bone regeneration. The objective is to evaluate if short-implants are superior in terms of better clinical outcomes, survival rates and safety, reduced surgical time, postoperative discomfort, and complication risk compared to conventional implants and bone regeneration.
Eligibility criteria
Qualifiers
Inform consent signed.
Adult patients (≥18 years old).
No pregnant women or without the desire to stay.
Periodontal and peri-implant health in a pristine or reduced periodontium.
Disqualifiers
Patients with uncontrolled systemic diseases.
Smoker patients (≥10 cig/day).
Patients taking medications that affect bone metabolism or immunologic disorders.
Patients allergic to penicillin.
Trial design
Treatments tested in this trial
- Ultra short implants
- Long implants with bone augmentation